{"content":"<li class=\"n-box-item date-title\" data-end=\"1499313599\" data-start=\"1499227200\" data-txt=\"Monday, December 23, 2019\">Wednesday, July  5, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3277124\" data-ts=\"1499290148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277124-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a>&nbsp;<font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a>&nbsp;<font color='green'>+4%</font>. <a href='https://seekingalpha.com/symbol/WIX' title='Wix.com'>WIX</a> <font color='green'>+1%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/EXTN' title='Exterran Corporation'>EXTN</a>&nbsp;<font color='red'>-10%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277124\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MLHR $RGC $SFM - After Hours Gainers / Losers https://seekingalpha.com/news/3277124-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3277124-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277113\" data-ts=\"1499288008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVCR\" target=\"_blank\">DVCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277113-diversicare-closes-on-alabama-skilled-nursing-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diversicare closes on Alabama skilled nursing facility</a></h4><ul>   <li>Diversicare (<a href=\"http://seekingalpha.com/symbol/DVCR\" target=\"_blank\">DVCR</a> <font color='green'>+6%</font>) has <a href=\"https://seekingalpha.com/pr/16878989-diversicare-completes-acquisition-skilled-nursing-facility\" target=\"_blank\">acquired a skilled nursing center</a> in Selma, Ala.</li>    <li>The acquisition of 103-bed facility Park Place (for $8.75M) gives Diversicare a total of 77 centers.</li>    <li>It's the 47th acquisition since beginning a focused expansion and the 11th that includes the underlying real estate, CEO Kelly Gill notes. That means it owns real estate on 18 of its 77 centers.</li>    <li>The company expects the new center to contribute more than $8M to revenues annually.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277113\" data-linked=\"Diversicare closes on Alabama skilled nursing facility\" data-tweet=\"$DVCR - Diversicare closes on Alabama skilled nursing facility https://seekingalpha.com/news/3277113-diversicare-closes-on-alabama-skilled-nursing-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/3277113-diversicare-closes-on-alabama-skilled-nursing-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277108\" data-ts=\"1499287294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMC\" target=\"_blank\">YUMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277108-yum-china-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yum China lower after earnings</a></h4><ul>     <li>Yum China (NYSE:<a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a>) matches estimates with its <a href=\"https://seekingalpha.com/pr/16879063-yum-china-reports-q2-store-sales-growth-3-percent-operating-profit-growth-64-percent-loyalty\" target=\"_blank\">Q2 report.</a></li>     <li>Same-store sales were up 3% during the period vs. the +2.4% consensus estimate. A&nbsp;4% gain at KFC was pulled back by a flat comp from Pizza Hut.</li>     <li>Restaurant margin as a percentage of sales improved 270 bps Y/Y to 15.3%. Restaurant margin was 16.0% of sales at KFC and 13.9% at Pizza Hut.</li>     <li>Delivery sales made up 13% of Yum's sales during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3277105-yum-china-eps-line-misses-revenue\" target=\"_blank\">Yum China EPS in-line, misses on revenue</a> (July 5)</li><li>YUMC&nbsp;<font color='red'>-5.56%</font>&nbsp;AH to $37.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277108\" data-linked=\"Yum China lower after earnings\" data-tweet=\"$YUMC - Yum China lower after earnings https://seekingalpha.com/news/3277108-yum-china-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3277108-yum-china-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277101\" data-ts=\"1499286610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNP\" target=\"_blank\">JNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277101-juniper-pharmaceutical-investors-reject-one-director\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Pharmaceutical investors reject one director</a></h4><ul>   <li>At an annual meeting, shareholders of Juniper Pharmaceuticals (<a href=\"http://seekingalpha.com/symbol/JNP\" target=\"_blank\">JNP</a> <font color='red'>-2.9%</font>) have <a href=\"https://seekingalpha.com/pr/16878983-juniper-pharmaceuticals-announces-results-2017-annual-meeting\" target=\"_blank\">spoken out against one of the seven directors</a> while signing off on other proxy items.</li>    <li>About 44% of votes cast were in favor of re-electing Dr. Frank Armstrong. He gave notice of resignation in accordance with by-laws after getting less than a majority.</li>    <li>Six other directors got majority support: Dr. Cristina Csimma, James Geraghty, Dr. Mary Ann Gray, Ann Merrifield, Dr. Nikin Patel and Alicia Secor.</li>    <li>Shareholders also approved PricewaterhouseCoopers as accountants; a nonbinding say-on-pay vote; and a nonbinding vote on setting annual say-on-pay votes.</li>    <li>The board will determine whether to accept or reject Armstrong's resignation and announce that decision within 90 days.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277101\" data-linked=\"Juniper Pharmaceutical investors reject one director\" data-tweet=\"$JNP - Juniper Pharmaceutical investors reject one director https://seekingalpha.com/news/3277101-juniper-pharmaceutical-investors-reject-one-director?source=tweet\" data-url=\"https://seekingalpha.com/news/3277101-juniper-pharmaceutical-investors-reject-one-director\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277097\" data-ts=\"1499286165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEN\" target=\"_blank\">PEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277097-penumbra-lifts-davis-to-chief-commercial-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penumbra lifts Davis to chief commercial officer</a></h4><ul>   <li>Penumbra (<a href=\"http://seekingalpha.com/symbol/PEN\" target=\"_blank\">PEN</a> <font color='green'>+2.1%</font>) has promoted Daniel Davis to the role of <a href=\"https://seekingalpha.com/pr/16878984-penumbra-inc-promotes-daniel-davis-chief-commercial-officer\" target=\"_blank\">chief commercial officer</a>.</li>    <li>Davis is currently the company's North American president after joining in 2007 as one of the sales team's first members.</li>    <li>He began serving as senior roles in marketing and sales management in 2011.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277097\" data-linked=\"Penumbra lifts Davis to chief commercial officer\" data-tweet=\"$PEN - Penumbra lifts Davis to chief commercial officer https://seekingalpha.com/news/3277097-penumbra-lifts-davis-to-chief-commercial-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3277097-penumbra-lifts-davis-to-chief-commercial-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277096\" data-ts=\"1499285905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277096-tesla-sheds-7-pace-of-deliveries-dissected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla sheds 7% as pace of deliveries dissected</a></h4><ul>     <li>Shares of Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) ended&nbsp;<font color='red'>down 7.24%</font>&nbsp;to $327.09 as they hit their lowest level in over a month.</li><li>Volume was nearly double normal activity, with 15.72M shares swapping hands.</li><li>Analyst commentary on Tesla was mixed today after the company reported a sequential drop in deliveries. Later in the week, Model 3 reviews could take the conversation in a different direction as the first deliveries are made.</li><li>Model 3 sales begin on July 28.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3277001-analysts-buzzing-tesla-update\" target=\"_blank\">Analysts buzzing after Tesla update</a> (July 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3276867-tesla-q2-sales-slowed-production-shortfall-cites-battery-pack-supply-issue\" target=\"_blank\">Tesla Q2 sales slowed by production shortfall; cites battery pack supply issue</a> (July 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277096\" data-linked=\"Tesla sheds 7% as pace of deliveries dissected\" data-tweet=\"$TSLA - Tesla sheds 7% as pace of deliveries dissected https://seekingalpha.com/news/3277096-tesla-sheds-7-pace-of-deliveries-dissected?source=tweet\" data-url=\"https://seekingalpha.com/news/3277096-tesla-sheds-7-pace-of-deliveries-dissected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>120&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277090\" data-ts=\"1499285247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277090-egalet-corp-raising-capital-shares-down-7_5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Egalet Corp. raising capital; shares down 7.5% after hours</a></h4><ul><li>The size of the <a href=\"https://seekingalpha.com/pr/16878963-egalet-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">common stock and warrant offering</a> isn't disclosed. The underwriter (Cantor Fitzgerald) will receive a greenshoe option of up to 15% of the number of securities sold in the offering.</li><li><a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a>&nbsp;<font color='red'>-7.5%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3277090\" data-linked=\"Egalet Corp. raising capital; shares down 7.5% after hours\" data-tweet=\"$EGLT $ZCOR - Egalet Corp. raising capital; shares down 7.5% after hours https://seekingalpha.com/news/3277090-egalet-corp-raising-capital-shares-down-7_5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3277090-egalet-corp-raising-capital-shares-down-7_5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277089\" data-ts=\"1499285208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLHR\" target=\"_blank\">MLHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277089-herman-miller-beats-0_09-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller beats by $0.09, misses on revenue</a></h4><ul><li>Herman Miller (NASDAQ:<a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>): Q4 EPS of $0.64 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $577.2M (-0.9% Y/Y) <font color='red'>misses by $6.33M</font>.</li><li>Shares <font color='green'>+2.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16878992-herman-miller-reports-fourth-quarter-fiscal-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3277089\" data-linked=\"Herman Miller beats by $0.09, misses on revenue\" data-tweet=\"$MLHR - Herman Miller beats by $0.09, misses on revenue https://seekingalpha.com/news/3277089-herman-miller-beats-0_09-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3277089-herman-miller-beats-0_09-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277083\" data-ts=\"1499284748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKE\" target=\"_blank\">OKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277083-oneok-upgraded-bmo-concerns-weakening-oil-prices-overblown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ONEOK upgraded at BMO as concerns about weakening oil prices &quot;overblown&quot;</a></h4><ul>     <li>ONEOK (<a href='https://seekingalpha.com/symbol/OKE' title='ONEOK, Inc.'>OKE</a> <font color='red'>-2.4%</font>) is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9739484/with-its-business-derisked-is-it-okay-to-invest-in-oneok\" target=\"_blank\">upgraded</a> to Outperform from Market Perform with a $59 price target, raised from $53, at BMO Capital, which says the large increase in the percentage of its EBITDA coming from fee-based and take-or-pay assets in the past few years has significantly reduced the company's risk.</li>     <li>BMO also believes concerns about weakening oil prices' impact on OKE are overblown, as lower oil prices probably will not affect guidance for a 9%-11% dividend compound annual growth rate through 2021, and the company should see a relatively stable production volume level of 1.7B cf/day through 2020.</li>     <li>Shares are lower amid a broad-based selloff today in energy names; also, Morgan Stanley resumed coverage on OKE with an Equal Weight, down from Overweight, with a $54 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277083\" data-linked=\"ONEOK upgraded at BMO as concerns about weakening oil prices &quot;overblown&quot;\" data-tweet=\"$OKE - ONEOK upgraded at BMO as concerns about weakening oil prices &quot;overblown&quot; https://seekingalpha.com/news/3277083-oneok-upgraded-bmo-concerns-weakening-oil-prices-overblown?source=tweet\" data-url=\"https://seekingalpha.com/news/3277083-oneok-upgraded-bmo-concerns-weakening-oil-prices-overblown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277079\" data-ts=\"1499283101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277079-american-airlines-tracks-toward-two-year-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines tracks toward two-year high</a></h4><ul><li>American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a>) is&nbsp;<font color='green'>up 1.77%</font>&nbsp;after Delta posts operating margin guidance slightly head of estimates and oil prices peel off 4% on the day.</li><li>The no-hedging airline paid an average fuel cost of $1.69 in Q1.</li><li>American trades just off its 52-week high of $51.95 and is also tracking toward its highest level in two years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3277008-key-metrics-impress-delta-air-lines\" target=\"_blank\">Key metrics impress at Delta Air Lines</a> (July 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3277079\" data-linked=\"American Airlines tracks toward two-year high\" data-tweet=\"$AAL - American Airlines tracks toward two-year high https://seekingalpha.com/news/3277079-american-airlines-tracks-toward-two-year-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3277079-american-airlines-tracks-toward-two-year-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277078\" data-ts=\"1499282809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WY\" target=\"_blank\">WY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277078-weyerhaeuser-downgraded-baml-shares-down-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weyerhaeuser downgraded at BAML; shares down 1.5%</a></h4><ul><li>Cash returns in timber are above the cost of capital, meaning an increase in supplies and an end to the rally in timberland prices, says analyst George Staphos, downgrading Weyerhaeuser (<a href='https://seekingalpha.com/symbol/WY' title='Weyerhaeuser Co.'>WY</a> <font color='red'>-1.5%</font>) to Neutral from Buy.</li><li>Staphos and team remain bullish on housing, but not so much on the wood to build with, thanks to the supply boost/pricing outlook.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3277078\" data-linked=\"Weyerhaeuser downgraded at BAML; shares down 1.5%\" data-tweet=\"$WY - Weyerhaeuser downgraded at BAML; shares down 1.5% https://seekingalpha.com/news/3277078-weyerhaeuser-downgraded-baml-shares-down-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3277078-weyerhaeuser-downgraded-baml-shares-down-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277072\" data-ts=\"1499279753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277072-defense-stocks-take-off-amid-escalating-u-s-north-korea-tensions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Defense stocks take off amid escalating U.S.-North Korea tensions</a></h4><ul>     <li>Defense stocks are on the rise after North Korea <a href=\"https://seekingalpha.com/news/3276903-u-s-confirms-n-korea-launched-icbm\" target=\"_blank\">launched</a> its first ballistic missile capable of reaching the continental U.S.; <a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.6%</font>, <a href='https://seekingalpha.com/symbol/RTN' title='Raytheon Company'>RTN</a> <font color='green'>+1.5%,</font> <a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color='green'>+1.4%</font>, <a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color='green'>+1.2%,</font> <a href='https://seekingalpha.com/symbol/GD' title='General Dynamics Corporation'>GD</a> <font color='green'>+0.9%</font>.</li>     <li>North Korea's actions may cause the U.S., Japan and South Korea to fund missile defense \"at an above average rate,\" particularly <a href=\"http://www.cnbc.com/2017/07/05/raytheon-may-benefit-from-bigger-missile-defense-spending.html\" target=\"_blank\">benefiting</a> RTN, Orbital ATK (<a href='https://seekingalpha.com/symbol/OA' title='Orbital ATK, Inc.'>OA</a> <font color='green'>+2.1%</font>) and Aerojet Rocketdyne (<a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc'>AJRD</a> <font color='green'>+2.3%</font>), according to Jefferies analysts.</li><li>While the U.S. continues to build its Ground Based Missile  Defense system, radar and rocket manufacturers such as RTN are  poised for federal funding, with geospatial imagery companies like  DigitalGlobe (DGI <font color='green'>+0.4%</font>) also positioned to benefit, Jefferies  says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277072\" data-linked=\"Defense stocks take off amid escalating U.S.-North Korea tensions\" data-tweet=\"$BA $BA $RTN - Defense stocks take off amid escalating U.S.-North Korea tensions https://seekingalpha.com/news/3277072-defense-stocks-take-off-amid-escalating-u-s-north-korea-tensions?source=tweet\" data-url=\"https://seekingalpha.com/news/3277072-defense-stocks-take-off-amid-escalating-u-s-north-korea-tensions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277068\" data-ts=\"1499278288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277068-ubs-charter-streaming-not-yet-big-espn-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS: Charter streaming not yet a big ESPN threat</a></h4><ul>   <li>Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-1.9%</font>) investors should be on watch to see how Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='green'>+1.6%</font>) handles its latest pass at a <a href=\"https://seekingalpha.com/news/3276380-charter-testing-live-tv-streaming-service\" target=\"_blank\">streaming television service</a> that <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9683409/how-will-charters-sports-free-cable-bundle-affect-disney\" target=\"_blank\">excludes sports mainstay ESPN</a> from its base tier, UBS says.</li>    <li>Spectrum TV Stream is starting at $19.95/month in large part by avoiding the high per-subscriber fees that ESPN demands, often estimated at between $6-$7/month. Meanwhile, ESPN's flagging number have presented the biggest downside catalyst to Disney stock in the past couple of years.</li>    <li>As for Disney worries, UBS analyst Doug Mitchelson says Stream is just a trial run for now and not being advertised on Charter's site, and since the offer isn't a virtual MVPD, it's limited by minimum penetration contracts.</li>    <li>Charter could shift up to 1M customers to Stream without running into contract problems with ESPN, says Mitchelson.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277068\" data-linked=\"UBS: Charter streaming not yet a big ESPN threat\" data-tweet=\"$DIS $DIS $CHTR - UBS: Charter streaming not yet a big ESPN threat https://seekingalpha.com/news/3277068-ubs-charter-streaming-not-yet-big-espn-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3277068-ubs-charter-streaming-not-yet-big-espn-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277066\" data-ts=\"1499277757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277066-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CCLP' title='CSI Compressco LP'>CCLP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/FMSA' title='Fairmount Santrol, Inc.'>FMSA</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CRZO' title='Carrizo Oil & Gas, Inc.'>CRZO</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277066\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$NADL $ZN $PQ - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3277066-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3277066-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277064\" data-ts=\"1499277668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277064-oil-market-materially-worsened-says-longtime-bull-andy-hall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil market has &quot;materially worsened&quot; says longtime bull Andy Hall</a></h4><ul><li>via Bloomberg</li><li>\"Not only did sentiment plumb new depths but fundamentals appear to have materially worsened,\" says Astenbeck Capital's Andy Hall in a July 3 letter to investors.</li><li>He takes note of U.S. shale drilling growing at a \"surprisingly fast rate,\" raising the odds for significant oversupply next year even with maintenance of OPEC supply cuts.</li><li>Prices, he says, could remain stuck near or below $50 per barrel.</li><li>Oil continues sharply lower on the session,&nbsp;<font color='red'>down 3.9%</font>&nbsp;to $45.22.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3277064\" data-linked=\"Oil market has &quot;materially worsened&quot; says longtime bull Andy Hall\" data-tweet=\"$USO $OIL $UWT - Oil market has &quot;materially worsened&quot; says longtime bull Andy Hall https://seekingalpha.com/news/3277064-oil-market-materially-worsened-says-longtime-bull-andy-hall?source=tweet\" data-url=\"https://seekingalpha.com/news/3277064-oil-market-materially-worsened-says-longtime-bull-andy-hall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277063\" data-ts=\"1499277380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277063-biotechs-head-higher-ahead-of-q2-earnings-dump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs head higher ahead of Q2 earnings dump</a></h4><ul><li>Biotechs are on the move after Bernstein expresses confidence on the sector ahead of Q2 earnings.</li><li>The firm predicts earnings beats for Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='green'>+1.7%</font>) and Jazz Pharmaceuticals (<a href='https://seekingalpha.com/symbol/JAZZ' title='Jazz Pharmaceuticals, Inc.'>JAZZ</a> <font color='red'>-0.4%</font>) when their numbers are spilled. On a broader look, Bernstein thinks concerns on drug prices are fading a bit.</li><li>Gainers today include Calithera Biosciences (<a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+11.1%</font>), Blueprint Medicines (<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines'>BPMC</a> <font color='green'>+8.7%</font>), Achillon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+8.4%</font>), ImmunoGen (<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+6.9%</font>) and Juno Therapeutics (<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+6.3%</font>).</li><li>Source: Bloomberg</li><li>The iShares Nasdaq Biotechnology Index (NASDAQ:<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a>) is&nbsp;<font color='green'>up 1.21%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277063\" data-linked=\"Biotechs head higher ahead of Q2 earnings dump\" data-tweet=\"$BIIB $BIIB $JAZZ - Biotechs head higher ahead of Q2 earnings dump https://seekingalpha.com/news/3277063-biotechs-head-higher-ahead-of-q2-earnings-dump?source=tweet\" data-url=\"https://seekingalpha.com/news/3277063-biotechs-head-higher-ahead-of-q2-earnings-dump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277061\" data-ts=\"1499276658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277061-premium-vod-threat-hangs-over-movie-theater-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premium VOD threat hangs over movie theater sector</a></h4><ul>     <li>Movie theater stocks are down again on concerns over the impact on traffic of premium video on demand initiatives.</li>     <li>Catching notice today from investors is a fresh note from Morgan Stanley warning on the \"collapsing\" movie exclusivity window as premium VOD lures in more studios.</li>     <li>MoffettNathanson was ahead of MS in calling out the threat of premium VOD in am insightful note posted a few weeks ago.</li>     <li>\"Under our base case analysis, film studios stand to gain $1.3 billion from PVOD to help offset their home video declines. This could lead to a net profit loss to exhibitors of $380 million even with beneficial splits of 15%, as the upside from sharing in PVOD revenues would not be enough to offset the lost profits from lower theatrical attendance,\" warned the firm.</li><li>MoffettNathanson also pointed to the impact Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+0.9%</font>) will have on the sector.</li>     <li>\"It is just as important to pay close attention to the impact Netflix will have on both exhibitors and studios. We estimate the company&rsquo;s ambitious goals of ramping up to 40-50 movies per year could ultimately cost the exhibition industry $280-$930 million in profits.</li><li>Source: Analyst note</li><li>AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='red'>-2.6%</font>), Regal Entertainment (<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a> <font color='red'>-4%</font>), Reading International (<a href='https://seekingalpha.com/symbol/RDI' title='Reading International, Inc.'>RDI</a> <font color='red'>-1.4%</font>), Cinemark Holdings (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color='red'>-2.5%</font>) and IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='red'>-2.2%</font>) are all lower on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277061\" data-linked=\"Premium VOD threat hangs over movie theater sector\" data-tweet=\"$NFLX $NFLX $AMC - Premium VOD threat hangs over movie theater sector https://seekingalpha.com/news/3277061-premium-vod-threat-hangs-over-movie-theater-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3277061-premium-vod-threat-hangs-over-movie-theater-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277058\" data-ts=\"1499275236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277058-alexion-higher-after-posting-strensiq-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexion higher after posting Strensiq update</a></h4><ul> <li>Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+3.9%</font>)&nbsp;announced that it reached a national funding agreement with the National Institute for       Health and Care Excellence and the National Health Service England&nbsp;on Strensiq for patients in England with       pediatric-onset hypophosphatasia.</li><li>Strensiq is approved in the European Union as a long-term enzyme       replacement therapy in patients with pediatric-onset HPP. Strensiq is       also approved in the U.S. for the treatment of patients with       perinatal-, infantile- and juvenile-onset HPP, as well as in Japan and       other countries. Alexion is currently progressing local funding       processes for Strensiq in additional countries worldwide.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16878168-alexion-reaches-funding-agreement-nice-nhs-england-strensiq-asfotase-alfa-patients-pediatric\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3277058\" data-linked=\"Alexion higher after posting Strensiq update\" data-tweet=\"$ALXN - Alexion higher after posting Strensiq update https://seekingalpha.com/news/3277058-alexion-higher-after-posting-strensiq-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3277058-alexion-higher-after-posting-strensiq-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277057\" data-ts=\"1499274969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277057-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MORE' title='Monogram Residential Trust, Inc.'>MORE</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SAR' title='Saratoga Investment Corp'>SAR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CNFR' title='Conifer Holdings'>CNFR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> RAS <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277057\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$MORE $LEJU $SAR - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3277057-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3277057-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277050\" data-ts=\"1499273299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHL\" target=\"_blank\">CHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277050-china-mobile-loses-favor-morgan-stanley-ahead-of-5g-spending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Mobile loses favor with Morgan Stanley ahead of 5G spending</a></h4><ul>   <li>Morgan Stanley has <a href=\"http://www.barrons.com/articles/china-mobile-downgrade-significant-deterioration-ahead-1499270910\" target=\"_blank\">dinged China's top telecom</a>, China Mobile (<a href=\"http://seekingalpha.com/symbol/CHL\" target=\"_blank\">CHL</a> <font color='red'>-1.9%</font>), with a two-notch downgrade and cut it from its Asia Pacific ex-Japan telecom portfolio, where it made up 10%.</li>    <li>China Unicom (<a href=\"http://seekingalpha.com/symbol/CHU\" target=\"_blank\">CHU</a> <font color='red'>-6.9%</font>) fell out of favor as well as MS sees a heavy 5G spending cycle ramping up beginning in 2019 with a peak cycle in 2020-2023. China Telecom (<a href=\"http://seekingalpha.com/symbol/CHA\" target=\"_blank\">CHA</a> <font color='red'>-0.8%</font>) remains in that portfolio as the only China stock.</li>    <li>\"This is a painful journey for CM,\" the firm says, \"considering: (a) higher capex for nationwide coverage using high spectrum bands (3-6GHz)</li>    <li>It's cutting 2018-2019 EPS estimates by 3-5%, now 5-7% below consensus.</li>    <li>Alongside cutting China Mobile and China Unicom from that ex-Japan AP telecom portfolio, it's reduced China's weighting overall (to 15% from 40%) with those moves, leaving China Telecom behind and adding India's Bharti and Indonesia's XL Axiata.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277050\" data-linked=\"China Mobile loses favor with Morgan Stanley ahead of 5G spending\" data-tweet=\"$CHL $CHL $CHU - China Mobile loses favor with Morgan Stanley ahead of 5G spending https://seekingalpha.com/news/3277050-china-mobile-loses-favor-morgan-stanley-ahead-of-5g-spending?source=tweet\" data-url=\"https://seekingalpha.com/news/3277050-china-mobile-loses-favor-morgan-stanley-ahead-of-5g-spending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277044\" data-ts=\"1499273048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277044-celgene-up-nearly-2-barrons-stays-bullish-leerink-notes-catalysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene up nearly 2% as Barron&#39;s stays bullish; Leerink notes catalysts</a></h4><ul><li>Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+1.9%</font>) up 32% since he turned bullish, but Barron's Jack Hough <a href=\"http://www.barrons.com/articles/celgene-could-rally-another-20-on-drug-gains-1498886222\" target=\"_blank\">says it could rally another</a> 20% thanks to a pipeline to help diversity away from Revlimid.</li><li>One of those drugs is the MS-treatment ozanimod, <a href=\"http://www.barrons.com/articles/celgene-whats-in-the-pipeline-1499269826\" target=\"_blank\">and the team at Leerink </a>- which recently upgraded Celgene - expects it to be one of the stock's bigger catalysts.</li><li>\"Ozanimod faces competition from multiple other second generation S1P&rsquo;s, but so far has the lower rates of atrioventricular block and bradycardia, and therefore the best chance of a differentiated label to justify branded drug pricing and support significant share gains in multiple sclerosis (and inflammatory bowel diseases). \"</li></ul><div class=\"tiny-share-widget\" data-id=\"3277044\" data-linked=\"Celgene up nearly 2% as Barron&#39;s stays bullish; Leerink notes catalysts\" data-tweet=\"$CELG - Celgene up nearly 2% as Barron&#39;s stays bullish; Leerink notes catalysts https://seekingalpha.com/news/3277044-celgene-up-nearly-2-barrons-stays-bullish-leerink-notes-catalysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3277044-celgene-up-nearly-2-barrons-stays-bullish-leerink-notes-catalysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277037\" data-ts=\"1499270483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277037-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+8%</font>. AOI <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-15%</font>. XNY <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/DORM' title='Dorman Products, Inc.'>DORM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277037\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SGOC $PYX $WKHS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3277037-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3277037-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277034\" data-ts=\"1499269846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIM\" target=\"_blank\">KIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277034-retail-traffic-report-mall-names-kimco-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail traffic report his mall names; Kimco down 5%</a></h4><ul><li>According to&nbsp;Bloomberg Intelligence analyst Poonam Goyal, retail traffic tumbled 8.1% in the week leading up to July 4.</li><li>Abercrombie &amp; Fitch, Macy&rsquo;s, J.C. Penney, Tailored Brands and Nordstrom reported slides in traffic and sales, says Goyal, noting those players are among the tenants of Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-5.2%</font>) and General Growth Properties (GGP <font color='red'>-3.1%</font>).</li><li>Retail Properties (<a href='https://seekingalpha.com/symbol/RPAI' title='Retail Properties of America'>RPAI</a> <font color='red'>-3.2%</font>), DDR (DDR <font color='red'>-3.1%</font>), Tanger Factor (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='red'>-3.3%</font>), Kite Realty (<a href='https://seekingalpha.com/symbol/KRG' title='Kite Realty Group Trust'>KRG</a> <font color='red'>-3.1%</font>), CBL &amp; Associates (<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-2.8%</font>), Weingarten Realty (<a href='https://seekingalpha.com/symbol/WRI' title='Weingarten Realty Investors'>WRI</a> <font color='red'>-3.4%</font>), PREIT (<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a> <font color='red'>-3.5%</font>), Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='red'>-3%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Co.'>MAC</a> <font color='red'>-2.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3277034\" data-linked=\"Retail traffic report his mall names; Kimco down 5%\" data-tweet=\"$KIM $KIM $BPR - Retail traffic report his mall names; Kimco down 5% https://seekingalpha.com/news/3277034-retail-traffic-report-mall-names-kimco-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3277034-retail-traffic-report-mall-names-kimco-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277030\" data-ts=\"1499269230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277030-barely-immunocellular-therapeutics-nearly-triples-pulls-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barely there ImmunoCellular Therapeutics nearly triples, pulls back</a></h4><ul><li>Starting the day with about a $3M market cap,&nbsp;ImmunoCellular Therapeutics (<a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a>) earlier this morning had nearly moved to a $9M valuation. Shares are currently&nbsp;<font color='green'>higher by 85%</font>&nbsp;to $1.67.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274697-immunocellular-suspends-patient-randomization-late-stage-study-ictminus-107-due-lack-money\" target=\"_blank\">ImmunoCellular suspends patient randomization in late-stage study of ICT-107 due to lack of money</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3277030\" data-linked=\"Barely there ImmunoCellular Therapeutics nearly triples, pulls back\" data-tweet=\"$IMUC - Barely there ImmunoCellular Therapeutics nearly triples, pulls back https://seekingalpha.com/news/3277030-barely-immunocellular-therapeutics-nearly-triples-pulls-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3277030-barely-immunocellular-therapeutics-nearly-triples-pulls-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277007\" data-ts=\"1499266866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277007-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CBPO' title='China Biologic Products, Inc.'>CBPO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ENZY' title='Enzymotec Ltd.'>ENZY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FLDM' title='Fluidigm Corporation'>FLDM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277007\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CLSN $NVRO $BLFS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3277007-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3277007-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277023\" data-ts=\"1499266706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277023-new-52-week-lows-for-rite-aid-and-freds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New 52-week lows for Rite Aid and Fred&#39;s</a></h4><ul> <li>Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-3.2%</font>) and Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-5.7%</font>) come off the holiday break with another swing lower.</li> <li>Both stocks etched out new 52-week lows in trading earlier as investors continue to reset expectations to the reworked Walgreens-Rite Aid deal.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3276590-rite-aid-looks-next-phase\" target=\"_blank\">Rite Aid looks to next phase</a> (June 30)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3277023\" data-linked=\"New 52-week lows for Rite Aid and Fred&#39;s\" data-tweet=\"$RAD $RAD $FRED - New 52-week lows for Rite Aid and Fred&#39;s https://seekingalpha.com/news/3277023-new-52-week-lows-for-rite-aid-and-freds?source=tweet\" data-url=\"https://seekingalpha.com/news/3277023-new-52-week-lows-for-rite-aid-and-freds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277018\" data-ts=\"1499264893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQR\" target=\"_blank\">EQR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277018-apartment-names-mull-monogram-residential-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apartment names mull Monogram Residential sale</a></h4><ul><li>Monogram Residential is&nbsp;<font color='green'>higher by 22.35%</font>&nbsp;to $11.99 after <a href=\"https://seekingalpha.com/news/3276928-monogram-residential-sold-12-share\" target=\"_blank\">agreeing to a sale</a> for $12 per share in cash.</li><li>The apartment REIT names are mixed following the news, with the larger players - who, in general, have the most high-end and coastal exposure (like Monogram) - in the green, and the smaller outfits lower.</li><li>Equity Residential (<a href='https://seekingalpha.com/symbol/EQR' title='Equity Residential'>EQR</a> <font color='green'>+0.7%</font>), AvalonBay (<a href='https://seekingalpha.com/symbol/AVB' title='AvalonBay Communities, Inc.'>AVB</a> <font color='green'>+0.9%</font>), Essex Property (<a href='https://seekingalpha.com/symbol/ESS' title='Essex Property Trust, Inc.'>ESS</a> <font color='green'>+0.4%</font>), UDR (<a href='https://seekingalpha.com/symbol/UDR' title='UDR, Inc.'>UDR</a> <font color='green'>+0.9%</font>), Aimco (<a href='https://seekingalpha.com/symbol/AIV' title='Apartment Investment & Management Company'>AIV</a> <font color='green'>+1.7%</font>), Investors Real Estate (<a href='https://seekingalpha.com/symbol/IRET' title='Investors Real Estate Trust'>IRET</a> <font color='red'>-3.7%</font>), Independence Realty (<a href='https://seekingalpha.com/symbol/IRT' title='Independence Realty Trust'>IRT</a> <font color='red'>-0.5%</font>), Bluerock Residential (<a href='https://seekingalpha.com/symbol/BRG' title='Bluerock Residential Growth REIT, Inc.'>BRG</a> <font color='red'>-1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3277018\" data-linked=\"Apartment names mull Monogram Residential sale\" data-tweet=\"$EQR $EQR $AVB - Apartment names mull Monogram Residential sale https://seekingalpha.com/news/3277018-apartment-names-mull-monogram-residential-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3277018-apartment-names-mull-monogram-residential-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277016\" data-ts=\"1499264669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLNG\" target=\"_blank\">GLNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277016-analysts-sing-praises-for-golar-lngs-first-flng-unit-see-inflection-point\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts sing praises for Golar LNG&#39;s first FLNG unit, see inflection point</a></h4><ul>     <li>Golar LNG (<a href='https://seekingalpha.com/symbol/GLNG' title='Golar LNG Limited'>GLNG</a> <font color='green'>+1.1%</font>) opens higher as analysts offer glowing reports following an event for the its first floating liquefied natural gas unit, the <em>Hilli Episeyo</em>, telling clients the occasion <a href=\"https://twitter.com/thenotablecalls/status/882593211880964099\" target=\"_blank\">marks an inflection point</a> for the company.</li>     <li>While GLNG has traded in sympathy with crude oil prices and the broader energy market, Stifel analysts believe a \"<a href=\"https://twitter.com/thenotablecalls/status/882593373097426944\" target=\"_blank\">significant decoupling</a>\" is likely to occur as catalysts such as the <em>Hilli Episeyo</em> startup begin to unfold, and that the firm's $36 stock price target <a href=\"https://twitter.com/thenotablecalls/status/882593396132634624\" target=\"_blank\">likely will prove conservative</a>.</li>     <li>Evercore ISI <a href=\"https://twitter.com/thenotablecalls/status/882593573937586176\" target=\"_blank\">ups its GLNG price target to $37</a> with a $57 bull case, saying it is increasingly confident that the <em>Hilli</em> FLNG will \"work\" as expected and dispels fears that the technology will fail.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277016\" data-linked=\"Analysts sing praises for Golar LNG&#39;s first FLNG unit, see inflection point\" data-tweet=\"$GLNG - Analysts sing praises for Golar LNG&#39;s first FLNG unit, see inflection point https://seekingalpha.com/news/3277016-analysts-sing-praises-for-golar-lngs-first-flng-unit-see-inflection-point?source=tweet\" data-url=\"https://seekingalpha.com/news/3277016-analysts-sing-praises-for-golar-lngs-first-flng-unit-see-inflection-point\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277011\" data-ts=\"1499263328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQM\" target=\"_blank\">SQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277011-reuters-chinese-firm-might-purchase-large-stake-in-lithium-miner-sqm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Chinese firm might purchase large stake in lithium miner SQM</a></h4><ul>     <li>Chinese P-E firm GSR Capital is <a href=\"https://www.reuters.com/article/us-sqm-m-a-china-idUSKBN19Q0K2\" target=\"_blank\">looking to buy a substantial holding</a> - perhaps a stake of ~20% - in Chilean lithium producer Sociedad Quimica y Minera (<a href='https://seekingalpha.com/symbol/SQM' title='Chemical & Mining Co. of Chile Inc.'>SQM</a> <font color='green'>+4.1%</font>), Reuters reports.</li>     <li>GSR, which has invested in clean technology and electric cars, met with Chile's government in April to discuss the potential purchase and now is moving towards a deal, according to the report.</li>     <li>SQM, which has access to vast mineral reserves in Chile and Argentina, has said it wanted to expand production as lithium demand continues to surge through its increased use in electric vehicles and mobile phones.</li></ul><div class=\"tiny-share-widget\" data-id=\"3277011\" data-linked=\"Reuters: Chinese firm might purchase large stake in lithium miner SQM\" data-tweet=\"$SQM - Reuters: Chinese firm might purchase large stake in lithium miner SQM https://seekingalpha.com/news/3277011-reuters-chinese-firm-might-purchase-large-stake-in-lithium-miner-sqm?source=tweet\" data-url=\"https://seekingalpha.com/news/3277011-reuters-chinese-firm-might-purchase-large-stake-in-lithium-miner-sqm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277002\" data-ts=\"1499262031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCN\" target=\"_blank\">AMCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277002-airmedia-group-regains-nasdaq-compliance-up-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AirMedia Group regains Nasdaq compliance, up 3.4%</a></h4><ul>   <li>China's AirMedia Group (<a href=\"http://seekingalpha.com/symbol/AMCN\" target=\"_blank\">AMCN</a> <font color='green'>+3.4%</font>) says it's <a href=\"https://seekingalpha.com/pr/16878187-airmedia-regained-compliance-nasdaq-listing-rules\" target=\"_blank\">regained compliance</a> with Nasdaq listing rules.</li>    <li>It filed its 20-F report on June 28 for the year ended Dec. 31, 2016.</li>    <li>That day it also got a <a href=\"https://seekingalpha.com/news/3275970-airmedia-receives-revised-buyout-offer\" target=\"_blank\">revision</a> of a go-private offer, for $4 per ADS in cash. That's the latest in a long-running plan (in fall 2015, execs planned to take it private at $6 per ADS). Those ADS are trading at $2.14 today.</li>    <li>The company had been notified on May 18 that it no longer met Nasdaq's period filing requirements, but is now back in compliance.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3277002\" data-linked=\"AirMedia Group regains Nasdaq compliance, up 3.4%\" data-tweet=\"$AMCN $ANTE - AirMedia Group regains Nasdaq compliance, up 3.4% https://seekingalpha.com/news/3277002-airmedia-group-regains-nasdaq-compliance-up-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3277002-airmedia-group-regains-nasdaq-compliance-up-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3277001\" data-ts=\"1499261623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3277001-analysts-buzzing-after-tesla-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts buzzing after Tesla update</a></h4><ul> <li>The analyst community is buzzing after Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) posts <a href=\"https://seekingalpha.com/pr/16877917-tesla-q2-2017-vehicle-production-deliveries\" target=\"_blank\">Q2 deliveries</a> of just over 22K and production of 25,708 vehicles. The company also said that it expects Model S and Model X deliveries in the second half of the year will top the tally from the first half of 2017.</li>  <li>Consumer Edge walks away from the latest development still confident that Tesla will top expectations. The firm thinks the narrative will shift to Model 3 buzz and reviews in short time. Shares are rated at Overweight and assigned a price target of $385.</li> <li>Goldman Sachs moves to a price target of $180 on Tesla after adjusting its valuation for the automotive segment. \"We remain sell rated on shares of TSLA where we see potential for downside as the Model 3 launch curve undershoots the company's production targets and as 2H17 margins likely disappoint,\" writes analyst David Tamberrino.</li> <li>Cowen reiterates its Underperform rating on Tesla on its view the ramp is too aggressive.</li> <li>KeyBanc splits it more down the middle, staying at Sector Weight with its expectation that investor expectations on profitability increase in 2018.</li> <li>The average Tesla price target from Wall Street firms is now $308, off the 8 Buys, 10 Holds and 6 Sells on the books.</li><li>Sources: Bloomberg and CNBC.</li><ul><li>TSLA <font color='red'>-3.24%</font> to $341.81.</li></ul> </ul><div class=\"tiny-share-widget\" data-id=\"3277001\" data-linked=\"Analysts buzzing after Tesla update\" data-tweet=\"$TSLA - Analysts buzzing after Tesla update https://seekingalpha.com/news/3277001-analysts-buzzing-after-tesla-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3277001-analysts-buzzing-after-tesla-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>156&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276995\" data-ts=\"1499261045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276995-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li>MSDI <font color='green'>+38%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>&nbsp;<font color='green'>+32%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3276978-dryships-announces-delivery-newcastlemax-vessel\" target=\"_blank\">announcement</a> of delivery of Newcastlemax vessel.</li>     <li><a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>&nbsp;<font color='green'>+28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3276974-celsion-completes-ovation-study-provides-update-advanced-stage-iii-iv-ovarian-cancer-shares\" target=\"_blank\">completion</a> of OVATION study and provides update on advanced stage III and IV Ovarian Cancer.</li>     <li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+24%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16878260-mtbc-announces-acquisition-regional-revenue-cycle-management-company\" target=\"_blank\">acquisition</a> of a&nbsp;Washington-based revenue cycle management company's client accounts and related business assets.</li>     <li><a href='https://seekingalpha.com/symbol/MORE' title='Monogram Residential Trust, Inc.'>MORE</a>&nbsp;<font color='green'>+22%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3276928\" target=\"_blank\">sold</a> for $12/share.</li>     <li><a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a>&nbsp;<font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3276972-fuelcell-soars-renewable-power-project\" target=\"_blank\">renewable</a> power project.</li>     <li><a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+8%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16878194-biolife-solutions-modifies-existing-credit-facility\" target=\"_blank\">modifying</a> its existing credit facilities.</li>     <li>OPXA <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16878431-immune-pharmaceuticals-oncology-subsidiary-cytovia-announces-additional-clinical-trial\" target=\"_blank\">publication</a> of clinical trial results on the use of Ceplene (histamine dihydrochloride) for relapse prevention in patients with acute myeloid leukemia.</li>     <li><a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3276995\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$INNT $DRYS $CLSN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3276995-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3276995-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276994\" data-ts=\"1499260984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276994-cb-and-i-secures-200m-lng-storage-tank-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I secures $200M LNG storage tank contract</a></h4><ul>     <li>CB&amp;I (NYSE:<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a>) <font color='green'>+2.1%</font> premarket after <a href=\"https://seekingalpha.com/pr/16878331-cb-awarded-storage-tank-contract-venture-global-lng\" target=\"_blank\">winning a ~$200M contract</a> by liquefied natural gas export company Venture Global for the engineering, procurement and construction of two LNG storage tanks for the Calcasieu Pass export facility in Louisiana.</li>     <li>Venture Global expects Calcasieu Pass to produce 10M metric tons/year of LNG supply; construction of the tanks is expected to begin in 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3276994\" data-linked=\"CB&amp;I secures $200M LNG storage tank contract\" data-tweet=\"$CBI - CB&amp;I secures $200M LNG storage tank contract https://seekingalpha.com/news/3276994-cb-and-i-secures-200m-lng-storage-tank-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3276994-cb-and-i-secures-200m-lng-storage-tank-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>175&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276987\" data-ts=\"1499260231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276987-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/ORLY' title='O&#39;Reilly Automotive, Inc.'>ORLY</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3276983-oreilly-automotive-tails-q2-sales-warning\" target=\"_blank\">reporting</a> Q2 comparable store sales results.</li><li><a href='https://seekingalpha.com/symbol/AAP' title='Advance Auto Parts, Inc.'>AAP</a>&nbsp;<font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3276987\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SPEX $DBD $ORLY - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3276987-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3276987-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276986\" data-ts=\"1499260057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZO\" target=\"_blank\">AZO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276986-auto-parts-stocks-on-watch-after-oreilly-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto parts stocks on watch after O&#39;Reilly warning</a></h4><ul> <li>The auto parts sector is taking on water after O'Reilly Automotive preannounced a Q2 same-store sales miss due to weak demand.</li> <li>Notable premarket decliners in the jittery sector include AutoZone (NYSE:<a href='https://seekingalpha.com/symbol/AZO' title='AutoZone, Inc'>AZO</a>)&nbsp;<font color='red'>-4.32%</font>, Genuine Parts (NYSE:<a href='https://seekingalpha.com/symbol/GPC' title='Genuine Parts Company'>GPC</a>)&nbsp;<font color='red'>-1.78%</font>&nbsp;and Advance Auto Parts (NYSE:<a href='https://seekingalpha.com/symbol/AAP' title='Advance Auto Parts, Inc.'>AAP</a>)&nbsp;<font color='red'>-6.72%</font>.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3276983-oreilly-automotive-tails-q2-sales-warning\" target=\"_blank\">O'Reilly Automotive tails off after Q2 sales warning</a> (July 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3276986\" data-linked=\"Auto parts stocks on watch after O&#39;Reilly warning\" data-tweet=\"$AZO $AZO $GPC - Auto parts stocks on watch after O&#39;Reilly warning https://seekingalpha.com/news/3276986-auto-parts-stocks-on-watch-after-oreilly-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3276986-auto-parts-stocks-on-watch-after-oreilly-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276985\" data-ts=\"1499259817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276985-pandoraplus-1_5-morgan-stanley-resumes-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +1.5% as Morgan Stanley resumes at Overweight</a></h4><ul>   <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color='green'>up 1.5%</font> premarket as Morgan Stanley resumes coverage of the stock at Overweight, pointing to a chance to refocus on advertising after a strategic investment.</li>    <li>An infusion of cash from Sirius XM (NASDAQ:<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>) leaves the ultimate strategic impact unclear for now, but it does shore up the balance sheet, writes Benjamin Swinburne: There's more than $650M in cash on a pro forma basis.</li>    <li>The company now has a strategic partner with a \"history of value creation,\" he says.</li>    <li>He's got a $12 price target, implying 36.8% upside from Monday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3276985\" data-linked=\"Pandora +1.5% as Morgan Stanley resumes at Overweight\" data-tweet=\"$P $P $SIRI - Pandora +1.5% as Morgan Stanley resumes at Overweight https://seekingalpha.com/news/3276985-pandoraplus-1_5-morgan-stanley-resumes-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3276985-pandoraplus-1_5-morgan-stanley-resumes-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276978\" data-ts=\"1499259219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276978-dryships-announces-delivery-of-newcastlemax-vessel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips announces delivery of Newcastlemax vessel</a></h4><ul> <li>DryShips (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>)&nbsp;announced that it took delivery of its second Newcastlemax drybulk vessel built in 2013.</li> <li>The company says the vessel will be employed under a time charter contract with a major coal and steel trader for a gross rate linked to the new Baltic Capesize Index plus 20%.</li>  <li>DRYS  <font color='green'>+23.30%</font> premarket to  $1.27.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16878462-dryships-inc-announces-successful-delivery-second-modern-newcastlemax-vessel\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3276978\" data-linked=\"DryShips announces delivery of Newcastlemax vessel\" data-tweet=\"$DRYS - DryShips announces delivery of Newcastlemax vessel https://seekingalpha.com/news/3276978-dryships-announces-delivery-of-newcastlemax-vessel?source=tweet\" data-url=\"https://seekingalpha.com/news/3276978-dryships-announces-delivery-of-newcastlemax-vessel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276974\" data-ts=\"1499258491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276974-celsion-completes-ovation-study-and-provides-update-on-advanced-stage-iii-and-iv-ovarian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsion completes OVATION study and provides update on advanced stage III and IV Ovarian Cancer; shares ahead 34% premarket</a></h4><ul> <li>Celsion Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) <a href=\"https://seekingalpha.com/pr/16878371-celsion-announces-completion-ovation-study-provides-update-immunotherapy-trial-advanced-stage\" target=\"_blank\">provides</a> an update on its Phase Ib dose escalating clinical trial (the OVATION Study) combining GEN-1 with neoadjuvant chemotherapy for the treatment of patients with Stage III and IV ovarian cancer followed by interval debulking surgery.</li>    <li>Enrollment got complete in the OVATION study. The clinical findings from the study enrolling 14 patients are as follows:</li><li>86% Objective Response Rate &#40;ORR&#41; in Phase IB dose escalating study.</li><li>100% ORR and 100% R0 (Margin Negative) surgical resection rate at highest dose cohort.</li>    <li>Final translational research data is being collected and will be available in Q3 for evaluation. Previous research findings from the first four patient cohorts are as below:</li><li>The ratio of CD8+ cells to immunosuppressive cells was increased in ~75% of patients suggesting an overall shift in the immune environment to pro-immune stimulatory following treatment with GEN-1.&nbsp; This increase is believed to be a good predictor of better overall survival.</li>    <li>Progression free survival update. Of the seven patients who have received GEN-1 treatment over one year ago, only one patient&rsquo;s cancer has progressed after 11.7 months compared to progression free survival &#40;PFS&#41; of 12 months. Of the remaining six patients, their average PFS is 15 months with the longest progression-free patient at 21 months. None of the patients in the third or fourth dose cohorts have progressed to date.</li><li>Shares are up&nbsp;<font color='green'>34%</font>&nbsp;premarket on modest volume.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3276974\" data-linked=\"Celsion completes OVATION study and provides update on advanced stage III and IV Ovarian Cancer; shares ahead 34% premarket\" data-tweet=\"$CLSN - Celsion completes OVATION study and provides update on advanced stage III and IV Ovarian Cancer; shares ahead 34% premarket https://seekingalpha.com/news/3276974-celsion-completes-ovation-study-and-provides-update-on-advanced-stage-iii-and-iv-ovarian?source=tweet\" data-url=\"https://seekingalpha.com/news/3276974-celsion-completes-ovation-study-and-provides-update-on-advanced-stage-iii-and-iv-ovarian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276972\" data-ts=\"1499258262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276972-fuelcell-soars-on-renewable-power-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell soars on renewable power project</a></h4><ul><li>FuelCell Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a>) has <a href=\"https://seekingalpha.com/pr/16878441-fuelcell-energy-announces-renewable-power-project-supply-california-electric-grid\" target=\"_blank\">announced</a> the execution of a digester gas purchase agreement  and site lease with the City of Tulare, California.</li><li>The pact enables the company to proceed under the California Bioenergy Market Adjustment Tariff program and sell power to the California electric grid.</li><li>FCEL <font color='green'>+25%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3276972\" data-linked=\"FuelCell soars on renewable power project\" data-tweet=\"$FCEL - FuelCell soars on renewable power project https://seekingalpha.com/news/3276972-fuelcell-soars-on-renewable-power-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3276972-fuelcell-soars-on-renewable-power-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276962\" data-ts=\"1499257487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276962-chemoursplus-4_6-citi-boosts-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemours +4.6% as Citi boosts rating</a></h4><ul><li>The firm <a href=\"https://www.highlightpress.com/citigroup-boosts-rating-on-chemours-company-the-cc/72479/clarence\" target=\"_blank\">upped</a> its rating on Chemours (NYSE:<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>) to Buy from Neutral, stating the recent stock selloff has created a good entry point.</li><li>Citi also raised its PT&nbsp;on shares to $45 from $43, expecting \"excellent\" regulation-driven growth for fluorochemicals, particularly Opteon adoption.</li></ul><div class=\"tiny-share-widget\" data-id=\"3276962\" data-linked=\"Chemours +4.6% as Citi boosts rating\" data-tweet=\"$CC - Chemours +4.6% as Citi boosts rating https://seekingalpha.com/news/3276962-chemoursplus-4_6-citi-boosts-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3276962-chemoursplus-4_6-citi-boosts-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276948\" data-ts=\"1499255029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276948-crude-oilminus-1_5-russia-reportedly-opposes-deeper-production-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil -1.5% as Russia reportedly opposes deeper production cuts</a></h4><ul>     <li>U.S. crude oil <font color='red'>-1.5%</font> to $46.37/bbl, snapping eight straight sessions of gains, following reports suggesting that <a href=\"https://www.bloomberg.com/news/articles/2017-07-05/oil-slows-longest-win-streak-in-2016-as-russia-opposes-more-cuts\" target=\"_blank\">Russia will oppose any deeper supply cuts</a> beyond the existing OPEC  agreement, which was extended into 2018.</li>     <li>Russia wants to continue with the current deal and believes any further supply curbs would send the wrong message to the market, according to the report, which cites unnamed government officials.</li>     <li>Also, Reuters reports <a href=\"http://uk.reuters.com/article/us-global-oil-idUKKBN19Q05V\" target=\"_blank\">OPEC exports rose by 450K bbl/day</a> in June from May and 1.9M vs. a year earlier, totaling 25.92M bbl/day.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3276948\" data-linked=\"Crude oil -1.5% as Russia reportedly opposes deeper production cuts\" data-tweet=\"$USO $OIL $UWT - Crude oil -1.5% as Russia reportedly opposes deeper production cuts https://seekingalpha.com/news/3276948-crude-oilminus-1_5-russia-reportedly-opposes-deeper-production-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3276948-crude-oilminus-1_5-russia-reportedly-opposes-deeper-production-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276946\" data-ts=\"1499254853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WP\" target=\"_blank\">WP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276946-vantiv-near-deal-for-worldpay-sky-news-updated-deal-agreed-to\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vantiv near deal for Worldpay - Sky News; updated: Deal agreed to</a></h4><ul><li>The U.K.-based payment services company&nbsp;<font color='green'>soared nearly 30%</font>&nbsp;on July 4 on reports of buyout interest from Vantiv (VNTV) and JPMorgan.</li><li>According to Sky News, a sale to Vantiv could be announced as soon as today. Vantiv shares are halted from trade. Worldpay (<a href='https://seekingalpha.com/symbol/WPYGY' title='Worldpay Group PLC ADR'>OTC:WPYGY</a>, <a href='https://seekingalpha.com/symbol/WDDYF' title='Worldpay Group PLC'>OTC:WDDYF</a>) is&nbsp;<font color='green'>higher by another 4%</font>&nbsp;in London action.</li><li>Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>) is seeing some premarket action on the news. It's currently&nbsp;<font color='green'>higher by 0.5%</font>.</li><li><strong>Updating at 8:00 ET:</strong> Vantiv has sealed a cash and stock deal valued at 395p per share. Post-deal, Worldpay holders would own about 41% of the combined company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3276946\" data-linked=\"Vantiv near deal for Worldpay - Sky News; updated: Deal agreed to\" data-tweet=\"$WP $WP $WPYGY - Vantiv near deal for Worldpay - Sky News; updated: Deal agreed to https://seekingalpha.com/news/3276946-vantiv-near-deal-for-worldpay-sky-news-updated-deal-agreed-to?source=tweet\" data-url=\"https://seekingalpha.com/news/3276946-vantiv-near-deal-for-worldpay-sky-news-updated-deal-agreed-to\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276945\" data-ts=\"1499254784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGNE\" target=\"_blank\">BGNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276945-beigene-initiates-trial-of-pdminus-1-antibody-bgb-a317-in-china-in-patients-uc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BeiGene initiates trial of PD-1 antibody BGB-A317 in China in patients with UC</a></h4><ul> <li>BeiGene (NASDAQ:<a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a>) <a href=\"https://seekingalpha.com/pr/16878265-beigene-initiates-pivotal-trial-pdminus-1-antibody-bgb-a317-china-patients-urothelial-cancer\" target=\"_blank\">announces</a> that the first patient was dosed in a pivotal clinical trial in China of <a href=\"http://www.beigene.com/pipeline/clinical-candidates/bgb-a317/\" target=\"_blank\">BGB-A317</a>, an investigational anti-PD-1 antibody, in patients with <a href=\"https://en.wikipedia.org/wiki/Transitional_cell_carcinoma\" target=\"_blank\">urothelial cancer</a> &#40;UC&#41;, more commonly known as bladder cancer.</li>       <li>The Phase II single-arm, multi-center trial is designed to investigate the efficacy and safety of BGB-A317 in patients with previously treated, PD-L1-positive, locally advanced or metastatic UC.</li><li>The trial&rsquo;s primary endpoint is the overall response rate &#40;ORR&#41; according to Response Evaluation Criteria in Solid Tumors Version 1.1, as assessed by independent review. Secondary endpoints include ORR as assessed by investigators, duration of response, disease control rate, progression-free survival, overall survival, safety, and tolerability.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3276945\" data-linked=\"BeiGene initiates trial of PD-1 antibody BGB-A317 in China in patients with UC\" data-tweet=\"$BGNE - BeiGene initiates trial of PD-1 antibody BGB-A317 in China in patients with UC https://seekingalpha.com/news/3276945-beigene-initiates-trial-of-pdminus-1-antibody-bgb-a317-in-china-in-patients-uc?source=tweet\" data-url=\"https://seekingalpha.com/news/3276945-beigene-initiates-trial-of-pdminus-1-antibody-bgb-a317-in-china-in-patients-uc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276930\" data-ts=\"1499252779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276930-bristol-myers-updates-on-opdivo-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers updates on Opdivo study</a></h4><ul> <li>Bristol-Myers (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) announces that a Phase 3 study on Opdivo for&nbsp;patients with high-risk melanoma met its       primary endpoint at a planned interim analysis.</li>     <li>\"These topline results support the potential promise of Opdivo as       a treatment option for patients with high-risk surgically resected       melanoma,&rdquo; says Bristol-Myers M.D. development lead&nbsp;Vicki Goodman.</li>     <li>The company says the Opdivo data will be submitted for presentation at an upcoming medical       conference.</li>     <li>BMY  <font color='green'>+1.223%</font> premarket to  $56.96.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16878215-phase-3-study-evaluating-safety-efficacy-adjuvant-opdivo-resected-high-risk-melanoma-patients\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3276930\" data-linked=\"Bristol-Myers updates on Opdivo study\" data-tweet=\"$BMY - Bristol-Myers updates on Opdivo study https://seekingalpha.com/news/3276930-bristol-myers-updates-on-opdivo-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3276930-bristol-myers-updates-on-opdivo-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3276928\" data-ts=\"1499252334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MORE\" target=\"_blank\">MORE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3276928-monogram-residential-sold-for-12-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monogram Residential sold for $12/share</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3276872-monogram-residential-near-sale-12-per-share-wsj\" target=\"_blank\">As floated after the close</a> on Monday, Monogram Residential (NYSE:<a href='https://seekingalpha.com/symbol/MORE' title='Monogram Residential Trust, Inc.'>MORE</a>) agrees to <a href=\"https://seekingalpha.com/pr/16878097-monogram-acquired-12_00-per-share-cash-greystar-led-fund\" target=\"_blank\">a sale to a group</a> led by Greystar Real Estate Partners for $12 per share in cash. Including debt, the deal is valued at about $3B.</li><li>The sale is expected to close sometime in H2.</li><li>It's going to mean some business for Walker &amp; Dunlop (NYSE:<a href='https://seekingalpha.com/symbol/WD' title='Walker & Dunlop, Inc.'>WD</a>), which has been retained <a href=\"https://seekingalpha.com/pr/16878224-walker-and-dunlop-secure-acquisition-financing-greystar\" target=\"_blank\">by Greystar to secure financing</a>. It will be the largest deal in Walker &amp; Dunlop history.</li></ul><div class=\"tiny-share-widget\" data-id=\"3276928\" data-linked=\"Monogram Residential sold for $12/share\" data-tweet=\"$MORE $MORE $WD - Monogram Residential sold for $12/share https://seekingalpha.com/news/3276928-monogram-residential-sold-for-12-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3276928-monogram-residential-sold-for-12-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM </div></div></li>","count":45,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}